# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001367644-25-000183
Filing Date
2025-09-05
Accepted
2025-09-05 17:23:20
Documents
20
Period of Report
2025-09-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | ebs-20250902.htm iXBRL | 8-K | 30165
2 | EX-10.1 | cyfendusmod.htm | EX-10.1 | 9187
3 | EX-99.1 | a09022025cyfenduspressrele.htm | EX-99.1 | 16294
8 |  | cyfendusmod001.jpg | GRAPHIC | 258636
9 |  | cyfendusmod002.jpg | GRAPHIC | 87407
10 |  | cyfendusmod003.jpg | GRAPHIC | 177446
11 |  | cyfendusmod004.jpg | GRAPHIC | 67808
12 |  | image2a.jpg | GRAPHIC | 7489
| Complete submission text file | 0001367644-25-000183.txt |  | 1039097

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | ebs-20250902.xsd | EX-101.SCH | 2059
5 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | ebs-20250902_def.xml | EX-101.DEF | 15289
6 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | ebs-20250902_lab.xml | EX-101.LAB | 26963
7 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | ebs-20250902_pre.xml | EX-101.PRE | 15991
22 | EXTRACTED XBRL INSTANCE DOCUMENT | ebs-20250902_htm.xml | XML | 2722

Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 251297550
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)